- Poster presentation
- Open Access
CRTC1 transcriptional coactivator is required for hepatitis B virus gene expression and replication
© Tang et al; licensee BioMed Central Ltd. 2014
- Published: 28 May 2014
- Hepatoma Cell
- Virus Gene Expression
- Liver Metabolism
- Severe Liver Disease
- Transcriptional Coactivator
Chronic hepatitis B virus (HBV) infection occurs in over 400 million people worldwide, 15-40% of whom will terminally develop severe liver diseases including hepatocellular carcinoma. Although development of HCC is a multi-step process, high HBV DNA level is a major risk factor for disease progression. Transcription of HBV from the cccDNA template is essential for its replication and requires CREB transcription factor, a master regulator of cell metabolism. However, transcriptional coactivators that facilitate CREB-dependent activation of HBV transcription remain to be identified and characterized.
In this study we demonstrate that cellular CRTC transcriptional coactivators, which also play important roles in liver metabolism, are required for HBV transcription and replication. CRTC1 expression was elevated in HBV-positive hepatoma cells and liver tissues. Ectopic expression of CRTC1 in HepG2 hepatoma cells stimulated preS2/S promoter activity of HBV, whereas overexpression of a dominant inactive form of CRTC1 resulted in suppression of activity. CRTC1 interacts with CREB and they are mutually required for the recruitment to preS2/S promoter and the activation of HBV transcription. The expression of pregenomic RNA (pgRNA) and the level of cccDNA were upregulated when CRTC1 was overexpressed, whereas the levels of pgRNA, cccDNA and HBsAg were diminished when CRTC1 was compromised. In addition, HBV transactivator protein HBx stabilized CRTC1 and promoted its activity on HBV transcription.
Our work reveals an essential role of CRTC1 in HBV transcription and an unrecognized link between liver metabolism and HBV oncogenesis mediated through a shared transcriptional coactivator.
The work was supported by Hong Kong HMRF (12111052 and 13121052) and SK YEE Medical Fund (2011).
- Siu YT, Chin KT, Siu KL, Choy EYW, Jeang KT, Jin DY: TORC1 and TORC2 coactivators are required for Tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol. 2006, 80: 7052-7059. 10.1128/JVI.00103-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Siu YT, Jin DY: CREB - a real culprit in oncogenesis. FEBS J. 2007, 274: 3224-3232. 10.1111/j.1742-4658.2007.05884.x.View ArticlePubMedGoogle Scholar
- Tang HMV, Gao WW, Chan CP, Siu YT, Wong CM, Kok KH, Ching YP, Takemori H, Jin DY: LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology. 2013, 10: 40-10.1186/1742-4690-10-40.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.